Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | BID | P55957 | 5/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.47 |
| ▸ | BCL2L1 | Q07817 | 4/20 | 0.47 |
| ▸ | BAK1 | Q16611 | 4/20 | 0.47 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.47 |
| ▸ | PPARA | Q07869 | 2/20 | 0.47 |
| ▸ | IAPP | P10997 | 2/20 | 0.47 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.47 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.47 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.47 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.47 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 2/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30056497 | 1.00 | ALOX5 (0.54) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL15228953 | 0.93 | ALOX5 (0.59) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL27981225 | 0.93 | ALOX5 (0.59) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL28328703 | 0.93 | ALOX5 (0.59) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL796853 | 0.89 | HMGCR (0.47) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL16829571 | 0.87 | ALOX5 (0.53) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL20237231 | 0.86 | DRD3 (0.44) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL30978247 | 0.85 | ALOX5 (0.42) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL11218181 | 0.84 | DRD3 (0.43) | ALOX5PTGS2BIDMCL1BCL2L1 | |
| SCHEMBL27829507 | 0.81 | DRD3 (0.46) | ALOX5PTGS2IAPPDRD3SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101914014-B | Method for synthesizing and purifying synthetic ester oil for cosmetics and synthetic ester oil for cosmetics obtained by same | BEIJING KTL TECHNOLOGY CO LTD | 2013-09-25 | — | — | CN | claimed |
| CN-101107274-B | Polymerization inhibitor for 1, 3-butadiene and method for inhibiting polymerization of 1, 3-butadiene by introducing the same | YEOCHUN NCC CO LTD | 2012-05-23 | — | — | CN | claimed |
| CN-101914014-A | Method for synthesizing and purifying synthetic ester oil for cosmetics and synthetic ester oil for cosmetics obtained by same | BEIJING BORUI CHUANGQI TECHNOLOGY CO LTD | 2010-12-15 | — | — | CN | claimed |
| US-20100143475-A1 | TRANSDERMAL THERAPEUTIC SYSTEM WITH TWO-PHASE RELEASE PROFILE | AXXONIS PHARMA AG (DE) | 2010-06-10 | — | — | US | claimed |
| CN-101107274-A | Polymerization inhibitor for 1,3-butadiene and a method of inhibiting polymerization of 1,3-butadiene by imputing thereof | YEOCHUN NCC CO LTD (KR) | 2008-01-16 | — | — | CN | claimed |
| WO-2006099946-A1 | TRANSDERMAL THERAPEUTIC SYSTEM | NEUROBIOTEC GMBH (DE) | 2006-09-28 | — | — | WO | claimed |
| CN-115232346-B | Plant fiber composite material for mobile phone packaging and preparation method thereof | 山东哈工生物科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-112724302-B | Ethylene-alpha-olefin copolymer, process for producing the same, ethylene resin composition, and film | 住友化学株式会社 | 2023-10-31 | — | — | CN | disclosed |
| CN-115232346-A | Plant fiber composite material for mobile phone packaging and preparation method thereof | 山东哈工生物科技有限公司 | 2022-10-25 | — | — | CN | disclosed |
| EP-3692131-B1 | COMPOSITION COMPRISING PRECURSORS FOR VOLATILES | HENKEL AG & CO KGAA (DE) | 2021-08-11 | — | — | EP | disclosed |
| EP-3692130-B1 | COMPOSITION COMPRISING PRECURSOR FOR VOLATILES | HENKEL AG & CO KGAA (DE) | 2021-08-04 | — | — | EP | disclosed |
| WO-2021115628-A1 | METHOD FOR PRODUCING PLATELET-SHAPED EFFECT PIGMENTS | GIESECKE+DEVRIENT CURRENCY TECHNOLOGY GMBH (DE) | 2021-06-17 | — | — | WO | disclosed |
| US-11014938-B2 | Compositions comprising precursors for volatiles | HENKEL AG & CO. KGAA (DE) | 2021-05-25 | — | — | US | disclosed |
| EP-1268382-A2 | ALKOXYLATED PERFUMED ALCOHOLS AND THE USE THEREOF | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001070661-A2 | ALKOXYLATED PERFUMED ALCOHOLS AND THE USE THEREOF | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-09-27 | — | — | WO | disclosed |
| EP-1112273-A1 | SILICIC-ACID ESTERS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000014091-A1 | SILICIC-ACID ESTERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-03-16 | — | — | WO | disclosed |
| EP-0653932-B1 | ARTIFICIAL-TAN AGENTS FOR THE SKIN | HENKEL KGAA (DE) | 1996-06-19 | — | — | EP | disclosed |
| EP-0653932-A1 | ARTIFICIAL-TAN AGENTS FOR THE SKIN. | HENKEL KGAA (DE) | 1995-05-24 | — | — | EP | disclosed |
| WO-1994003148-A2 | ARTIFICIAL-TAN AGENTS FOR THE SKIN | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1994-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11014938-B2 | Compositions comprising precursors for volatiles | DNMT1, DNMT3L, AZI2 | ALOX5 531/4885PTGS2 3750/4885BID 1565/4885 |
| US-20100143475-A1 | TRANSDERMAL THERAPEUTIC SYSTEM WITH TWO-PHASE RELEASE PROFILE | TTPA, ALOX12, ALOX15B | ALOX5 34/4885PTGS2 971/4885BID 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.